BrightSpring Health Services, Inc. (BTSG) Form 10-Q — Oct 30, 2026
BrightSpring Health Services reported Q3 2026 revenue of $4.2 billion, up 26.4% year over year, with Pharmacy Solutions revenue up 25.8% to $3.7 billion and Provider Services up 31.0% to $480.8 million. Net income from continuing operations rose $63.3 million to $100.8 million, diluted EPS increased from $0.17 to $0.46, and Adjusted EBITDA grew 42.0% to $227.8 million. Company leverage stood at 1.79x at quarter end, with cash of $717.8 million boosted by $810.9 million of proceeds from the Community Living divestiture completed in March 2026. Growth was aided by the Amedisys and LHC Branches Acquisition, which contributed $232.5 million of nine-month revenue.
Key figures
- Eps
- 0.45
- Revenue
- 4213234000
- Net Income
- 100299000
- Revenue Yoy
- 26.4
- Total Assets
- 6266621000
- Cash Position
- 717840000
- Shares Outstanding
- 198814320
- Company leverage
- 1.79x
- Nine month revenue
- 11700095000
- Teu installment rate
- 6.75% per year
- Nine month net income
- 333118000
- Q3 revenue growth pct
- 26.4
- Debt repaid nine months
- 332300000
- Q3 diluted eps prior year
- 0.17
- Adjusted ebitda growth pct
- 42
- Segment ebitda pharmacy q3
- 201980000
- Segment ebitda provider q3
- 78952000
- Consigned inventory millions
- 111.6
- Provider services revenue q3
- 480806000
- Pharmacy solutions revenue q3
- 3732428000
- Share repurchases nine months
- 120000000
- Adjusted ebitda q3 2026 millions
- 227.8
- Teu amortizing notes current millions
- 13
- Amedisys lhc acquisition price millions
- 238.5
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.